T he controversial study on the Covaxin vaccine, published by a team of researchers at the Banaras Hindu University (BHU) has ...

澳大利亚药监局（TGA）在周一发布声明，确认中国国药疫苗（BBIBP-CorV，由Sinopharm生产）和印度Covaxin疫苗（由Bharat Biotech生产）为“认可”的疫苗 ...

A volunteer gets a jab at a clinical trial for Covaxin in the western city of Ahmedabad How can a coronavirus vaccine be cleared for emergency use by millions of vulnerable people in a "clinical ...

Covaxin, made by Bharat Biotech, has been granted emergency use permission for the six-12 age group, health minister Mansukh Mandaviya tweeted. It is already administered to children aged 12-18 ...

Armed with new data from its development partner Bharat Biotech, Ocugen is planning to press ahead with plans to file for approval of their COVID-19 vaccine Covaxin in the US and Canada.

The BJP shared a series of posts about a report by Mediapart, which explored OCCRP's funding. The party shared this report to ...

Bharat Biotech ’s COVID-19 vaccine Covaxin is being priced at ₹600 for state government hospitals and ₹1200 for private hospitals, the company said in a press statement, which came out late ...

Amid global scrutiny surrounding AstraZeneca’s coronavirus jab due to rare side effects, Bharat Biotech on Thursday released a statement about the indigenous Covaxin saying it is safe and devoid ...

Hyderabad, Covaxin, the Covid vaccine developed by Bharat Biotech, effectively neutralizes UK variants of SARS-CoV-2 reducing the possibility of mutant virus escape, finds a study. According to ...

The interim results of the Phase-3 trials for Covaxin have shown a clinical efficacy of 78% against mild, moderate and severe Covid-19 disease, makers Bharat Biotech and Indian Council of Medical ...

Anil Vij also tweeted that he has offered to become the first volunteer to be vaccinated for the same. Coronavirus Covid-19 vaccine Covaxin Phase 3 trial in India: Haryana Health Minister Anil Vij ...